These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33212405)

  • 1. The association between placebo arm inclusion and adverse event rates in antidepressant randomized controlled trials: An examination of the Nocebo Effect.
    Cheung CP; Thiyagarajah MT; Abraha HY; Liu CS; Lanctôt KL; Kiss AJ; Saleem M; Juda A; Levitt AJ; Schaffer A; Cheung AH; Sinyor M
    J Affect Disord; 2021 Feb; 280(Pt A):140-147. PubMed ID: 33212405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant-placebo differences for specific adverse events in major depressive disorder: A systematic review.
    Sinyor M; Cheung CP; Abraha HY; Lanctôt KL; Saleem M; Liu CS; Li A; Juda A; Levitt AJ; Cheung AH; Schaffer A
    J Affect Disord; 2020 Apr; 267():185-190. PubMed ID: 32217218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
    Sinyor M; Levitt AJ; Cheung AH; Schaffer A; Kiss A; Dowlati Y; Lanctôt KL
    J Clin Psychiatry; 2010 Mar; 71(3):270-9. PubMed ID: 20122371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocebo in clinical trials for depression: a meta-analysis.
    Mitsikostas DD; Mantonakis L; Chalarakis N
    Psychiatry Res; 2014 Jan; 215(1):82-6. PubMed ID: 24210741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ma C; Panaccione NR; Nguyen TM; Guizzetti L; Parker CE; Hussein IM; Vande Casteele N; Khanna R; Dulai PS; Singh S; Feagan BG; Jairath V
    J Crohns Colitis; 2019 Sep; 13(9):1201-1216. PubMed ID: 31111881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the Nocebo Effect in Trials of Neuromodulators for Use in Disorders of Gut-Brain Interaction.
    Glissen Brown JR; Sanayei A; Proctor S; Flanagan R; Ballou S; Bain PA; Nee J
    Am J Gastroenterol; 2023 Apr; 118(4):692-701. PubMed ID: 36563308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo and nocebo responses in randomized controlled trials of Janus kinase inhibitor monotherapy for rheumatoid arthritis : A meta-analysis.
    Sung YK; Lee YH
    Z Rheumatol; 2022 Jun; 81(5):430-437. PubMed ID: 33687525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo and nocebo reactions in randomized trials of pharmacological treatments for persistent depressive disorder. A meta-regression analysis.
    Meister R; Jansen A; Härter M; Nestoriuc Y; Kriston L
    J Affect Disord; 2017 Jun; 215():288-298. PubMed ID: 28363152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocebo response in dentistry: A systematic review and meta-analysis of adverse events in analgesic trials of third molar removal.
    Watanabe T; Sieg M; Lunde SJ; Persson M; Taneja P; Baad-Hansen L; Pigg M; Vase L
    J Oral Rehabil; 2023 Apr; 50(4):332-342. PubMed ID: 36648379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials.
    Zis P; Mitsikostas DD
    J Neurol Sci; 2015 Aug; 355(1-2):94-100. PubMed ID: 26073486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 Oct; 73(10):1300-6. PubMed ID: 23140647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis.
    Salanti G; Chaimani A; Furukawa TA; Higgins JPT; Ogawa Y; Cipriani A; Egger M
    Int J Epidemiol; 2018 Oct; 47(5):1454-1464. PubMed ID: 29878123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocebo effects and psychotropic drug action.
    Amanzio M
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):159-61. PubMed ID: 25494811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
    Papakostas GI; Fava M
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2015 Sep; 69(9):978-97. PubMed ID: 26250067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocebo effects in the treatment of major depression: results from an individual study participant-level meta-analysis of the placebo arm of duloxetine clinical trials.
    Dodd S; Schacht A; Kelin K; Dueñas H; Reed VA; Williams LJ; Quirk FH; Malhi GS; Berk M
    J Clin Psychiatry; 2015 Jun; 76(6):702-11. PubMed ID: 26132671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocebo effect in multiple system atrophy: systematic review and meta-analysis of placebo-controlled clinical trials.
    Wang ZX; Zhang NN; Zhao HX; Song J
    Neurol Sci; 2022 Feb; 43(2):899-905. PubMed ID: 34973075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.